RENAISSANCE TECHNOLOGIES LLC
Institutional investor · Portfolio as of Q4 2019
Top Holdings3,469 positions
BRISTOL-MYERS SQUIBB CO | 60.2M | $3.9B | 3.0% | $49.58 | 0.00% | 1 qtr | First report 0 |
TESLA INC | 3.9M | $1.6B | 1.3% | $27.89 | 0.00% | 1 qtr | First report 0 |
VERISIGN INC | 8.3M | $1.6B | 1.2% | $190.67 | 0.00% | 1 qtr | First report 0 |
Vertex Pharmaceuticals Incorporated | 7.1M | $1.5B | 1.2% | $218.95 | 0.00% | 1 qtr | First report 0 |
NOVO-NORDISK A S | 26.2M | $1.5B | 1.2% | $24.76 | 0.00% | 1 qtr | First report 0 |
CHIPOTLE MEXICAN GRILL INC | 1.8M | $1.5B | 1.1% | $16.74 | 0.00% | 1 qtr | First report 0 |
BIOGEN INC | 4.6M | $1.4B | 1.0% | $296.73 | 0.00% | 1 qtr | First report 0 |
Palo Alto Networks Inc | 5.7M | $1.3B | 1.0% | $38.54 | 0.00% | 1 qtr | First report 0 |
GILEAD SCIENCES INC | 17M | $1.1B | 0.8% | $50.63 | 0.00% | 1 qtr | First report 0 |
HUMANA INC | 3M | $1.1B | 0.8% | $345.14 | 0.00% | 1 qtr | First report 0 |
Walmart Inc | 8.9M | $1.1B | 0.8% | $36.17 | 0.00% | 1 qtr | First report 0 |
AbbVie Inc. | 11.8M | $1B | 0.8% | $68.47 | 0.00% | 1 qtr | First report 0 |
ALLERGAN PLC | 5M | $959.6M | 0.7% | — | — | 1 qtr | First report 0 |
PETROLEO BRASILEIRO SA PETRO | 56.7M | $903.7M | 0.7% | $4.61 | 0.00% | 1 qtr | First report 0 |
| 19M | $894.1M | 0.7% | — | — | 1 qtr | First report 0 | |
General Electric Co. | 75.6M | $844M | 0.6% | $53.71 | 0.00% | 1 qtr | First report 0 |
Amgen Inc. | 3.2M | $761.7M | 0.6% | $198.37 | 0.00% | 1 qtr | First report 0 |
| 6.1M | $731.9M | 0.6% | — | — | 1 qtr | First report 0 | |
ALIGN TECHNOLOGY INC | 2.6M | $728.5M | 0.6% | $275.63 | 0.00% | 1 qtr | First report 0 |
Monster Beverage Corp | 11.5M | $727.8M | 0.6% | $31.78 | 0.00% | 1 qtr | First report 0 |
RENAISSANCE TECHNOLOGIES LLC manages $130.1B across 3469 positions as of Q4 2019. Top holdings: BMY (3.0%), TSLA (1.3%), VRSN (1.2%). Fund DNA: Diversified Scout. HoldingsIntel Score: 2.5/5.0.
First quarter we have for this fund: 3469 positions, nothing earlier to compare. No standout high-conviction moves this quarter. Portfolio: $130.1B across 3469 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR